However, inactivating mutations in p53 occurs in up to 60% of AIDS-BL [36] and 40% of AIDS-DLBCL [37] often leading to enhanced p53 protein stability and its accumulation in tumors [38]. This evidence concerns the gene TP53 and Burkitt lymphoma.